APP and Alzheimer disease: In the same AD model, Mori et al. [106] found that ferulic acid (30 mg/kg orally for 6 months) decreased Aβ production from APP and neuroinflammation, and stabilized oxidative stress; consequently, cognitive tasks were improved.